Literature DB >> 20800551

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.

M Guo1, Z J Chen, N S Macklon, Y H Shi, H E Westerveld, M J Eijkemans, B C J M Fauser, A J Goverde.   

Abstract

Polycystic ovary syndrome (PCOS) is strongly associated with metabolic abnormalities in Western women. However, data from other populations and geographical regions are scarce. This study evaluated cardiovascular and metabolic risk factors in Chinese infertile women diagnosed with PCOS using the 2003 Rotterdam consensus criteria. A total of 615 women representing the four PCOS phenotypes (oligo- or anovulation (AO)+hyperandrogenism (HA)+polycystic ovaries (PCO), AO+HA, AO+PCO and HA+PCO) underwent standardized metabolic screening including a 75g oral glucose tolerance test. All groups presented with similar reproductive characteristics, with the only difference being a significantly higher Ferriman-Gallwey score for hirsutism (P=0.01) in the subgroup characterized by HA+PCO. Overall, the prevalence of metabolic syndrome was 6.4%, with no difference among the four groups (range of 2.3-12.2%). Metabolic syndrome was associated with body mass index (P<0.001), waist/hip ratio (P=0.002), index of insulin resistance (P=0.005) and fasting insulin (P=0.009) in multivariate analysis. Compared with Caucasians and Chinese women in Westernized societies, mainland Chinese women with PCOS have a low risk of metabolic syndrome and its presence does not vary across the specific PCOS phenotypes. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800551     DOI: 10.1016/j.rbmo.2010.04.032

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  10 in total

1.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

2.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

3.  The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.

Authors:  Mohammed Altigani Abdalla; Harshal Deshmukh; Irfaan Mohammed; Stephen Atkin; Marie Reid; Thozhukat Sathyapalan
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

4.  Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women.

Authors:  Roshan Dadachanji; Anushree Patil; Beena Joshi; Srabani Mukherjee
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

5.  Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice.

Authors:  Youngjae Ryu; Yong Jin Kim; Yoon Young Kim; Jungwoo Kim; Sung Woo Kim; Hoon Kim; Seung Yup Ku
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

6.  Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Małgorzata Kałużna; Magdalena Czlapka-Matyasik; Pola Kompf; Jerzy Moczko; Katarzyna Wachowiak-Ochmańska; Adam Janicki; Karolina Samarzewska; Marek Ruchała; Katarzyna Ziemnicka
Journal:  Ther Adv Endocrinol Metab       Date:  2022-01-10       Impact factor: 3.565

7.  The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome.

Authors:  Stefano Palomba; Angela Falbo; Tiziana Russo; Laura Rivoli; Marcello Orio; Andrea Gregorio Cosco; Raffaella Vero; Carmelo Capula; Achille Tolino; Fulvio Zullo; Annamaria Colao; Francesco Orio
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

8.  Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls.

Authors:  Jin Ju Kim; Young Min Choi; Jin Hwa Kang; Kyu Ri Hwang; Soo Jin Chae; Sun Mie Kim; Seung Yup Ku; Seok Hyun Kim; Jung Gu Kim; Shin Yong Moon
Journal:  Obstet Gynecol Sci       Date:  2013-07-15

Review 9.  Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis.

Authors:  Rui Yang; Shuo Yang; Rong Li; Ping Liu; Jie Qiao; Yanwu Zhang
Journal:  Reprod Biol Endocrinol       Date:  2016-10-18       Impact factor: 5.211

Review 10.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.